Charles River Laboratories reported $319.64M in Stock for its fiscal quarter ending in September of 2026.





Stock Change Date
Agilent USD 1.12B 28M Jun/2026
Align Technology USD 212.24M 2.7M Jun/2026
Bio-Rad Laboratories USD 783.9M 3.3M Sep/2026
Bruker USD 1.12B 1.4M Jun/2026
Cardinal Health USD 18.4B 1.1B Sep/2026
Charles River Laboratories USD 319.64M 26.62M Sep/2026
Cigna USD 5.56B 292M Sep/2026
CVS Health USD 18.24B 618M Sep/2026
Danaher USD 3.13B 126M Sep/2026
Dentsply International USD 707M 42M Sep/2026
Elevance Health USD 0 0 Dec/2024
Illumina USD 667M 38M Sep/2026
Incyte USD 134.25M 21.71M Sep/2026
Intrexon USD 287K 68K Dec/2022
Laboratory Of America USD 538.4M 23.8M Sep/2026
Lakefront Biotherapeutics EUR 17.69M 4.8M Mar/2026
Lonza CHF 1.68B 163M Dec/2025
McKesson USD 28.22B 1.96B Sep/2026
Merck EUR 4.89B 104M Jun/2026
Mettler Toledo International USD 439.66M 28.1M Sep/2026
Novartis USD 6.1B 116M Sep/2026
Pfizer USD 10.02B 77M Sep/2026
Quest Diagnostics USD 218M 15M Sep/2026
Revvity USD 388.85M 10.35M Sep/2026
Thermo Fisher Scientific USD 5.64B 16M Sep/2026
United Therapeutics USD 201.9M 8.1M Sep/2026
UnitedHealth USD 280M 280M Dec/2023
Waters USD 1.32B 53M Sep/2026
West Pharmaceutical Services USD 464.7M 17.3M Sep/2026